Literature DB >> 33319435

Spanish experience with heart transplants from controlled donation after the circulatory determination of death using thoraco-abdominal normothermic regional perfusion and cold storage.

Eduardo Miñambres1, Mario Royo-Villanova2, Marina Pérez-Redondo3, Elisabeth Coll4, Susana Villar-García5, Sergio J Canovas6, Juan Francisco Nistal7, Iris P Garrido8, Manuel Gómez-Bueno9, Manuel Cobo10, Beatriz Dominguez-Gil4.   

Abstract

Heart transplantation from controlled donation after the circulatory determination of death (cDCDD) may help to increase the availability of hearts for transplantation. During 2020, four heart transplants were performed at three different Spanish hospitals based on the use of thoraco-abdominal normothermic regional perfusion (TA-NRP) followed by cold storage (CS). All donors were young adults <45 years. The functional warms ischemic time ranged from 8 to 16 minutes. In all cases, the heart recovered sinus rhythm within 1 minute of TA-NRP. TA-NRP was weaned off or decreased <1L within 25 minutes. No recipient required mechanical support after transplantation and all were immediately extubated and discharged home (median hospital stay: 21 days) with an excellent outcome. Four livers, eight kidneys, and two pancreata were also recovered and transplanted. All abdominal grafts recipients experienced an excellent outcome. The use of TA-NRP makes heart transplantation feasible and allows assessing heart function before organ procurement without any negative impact on the preservation of abdominal organs. The use of TA-NRP in cDCDD heart donors in conjunction with cold storage following retrieval can eliminate the need to use ex situ machine perfusion devices, making cDCDD heart transplantation economically possible in other countries.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research / practice; donors and donation: donation after circulatory death (DCD); extracorporeal membrane oxygenation (ECMO); heart (allograft) function / dysfunction; heart transplantation / cardiology; organ procurement and allocation

Year:  2021        PMID: 33319435     DOI: 10.1111/ajt.16446

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.

Authors:  Emad Alamouti-Fard; Pankaj Garg; Ishaq J Wadiwala; John H Yazji; Mohammad Alomari; Md Walid Akram Hussain; Mohamed S Elawady; Samuel Jacob
Journal:  Cureus       Date:  2022-06-29

2.  Multiorgan retrieval and preservation of the thoracic and abdominal organs in Maastricht III donors.

Authors:  Daniel Casanova; Federico Castillo; Eduardo Miñambres
Journal:  World J Transplant       Date:  2022-05-18

3.  Expanding controlled donation after the circulatory determination of death: statement from an international collaborative.

Authors:  Beatriz Domínguez-Gil; Nancy Ascher; Alexander M Capron; Dale Gardiner; Alexander R Manara; James L Bernat; Eduardo Miñambres; Jeffrey M Singh; Robert J Porte; James F Markmann; Kumud Dhital; Didier Ledoux; Constantino Fondevila; Sarah Hosgood; Dirk Van Raemdonck; Shaf Keshavjee; James Dubois; Andrew McGee; Galen V Henderson; Alexandra K Glazier; Stefan G Tullius; Sam D Shemie; Francis L Delmonico
Journal:  Intensive Care Med       Date:  2021-02-26       Impact factor: 17.440

Review 4.  Heart Donation and Preservation: Historical Perspectives, Current Technologies, and Future Directions.

Authors:  Nicholas R Hess; Luke A Ziegler; David J Kaczorowski
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

5.  Critical warm ischemia time point for cardiac donation after circulatory death.

Authors:  Silvia Sánchez-Cámara; Mari C Asensio-López; Mario Royo-Villanova; Fernando Soler; Rubén Jara-Rubio; Jose Francisco Garrido-Peñalver; Eduardo Pinar; Álvaro Hernández-Vicente; Jose Antonio Hurtado; Antonio Lax; Domingo A Pascual-Figal
Journal:  Am J Transplant       Date:  2022-02-21       Impact factor: 9.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.